Troy A. Carter recently disclosed $28.8K of fundraising in a Pre-Primary FEC disclosure filed on July 26th, 2026. This was ...

Nurix Therapeutics has made significant advancements, including dosing the first patient in the Phase 3 DAYBreak CLL-306 ...

Apnimed, Inc., a clinical pharmaceutical company focused on innovative oral therapies for sleep-related breathing disorders, ...

Oncolytics Biotech® Inc. announced significant progress in its intellectual property strategy regarding its immunotherapy ...

ArriVent BioPharma has dosed its first patient in a Phase 1 trial for ARR-002, targeting ovarian and endometrial cancers.

Ernexa Therapeutics, a company focused on developing innovative cell therapies for advanced cancers, has announced a live ...

Howard Hughes Holdings will release Q3 earnings on November 5 and host a conference call on November 6.

Healthcare Realty Trust's 2025 Corporate Responsibility Report details ESG achievements, emissions reductions, and green ...

PROCEPT BioRobotics Corporation announced it will report its financial results for the third quarter of 2026 on November 4, ...

Organogenesis Holdings Inc. announced that it will report its third quarter financial results for fiscal year 2026 on ...

This partnership will combine FormFactor's expertise in probe technologies and test engineering with Teradyne's automated ...

MYR Group will attend the Cantor Convergence conference to engage with institutional investors on November 11, 2026.